Conavi Medical Corp. CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.63% | -60.30% | 61.39% | 58.17% | 72.97% |
| Total Depreciation and Amortization | 31.02% | -13.00% | -16.02% | 24.21% | -9.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -82.15% | -- |
| Total Other Non-Cash Items | 105.50% | 118.28% | -234.87% | -77.23% | -120.09% |
| Change in Net Operating Assets | 192.34% | -264.54% | 153.34% | -141.07% | -212.17% |
| Cash from Operations | 64.80% | -92.46% | 51.16% | -10.45% | -40.23% |
| Capital Expenditure | -7,495.35% | 80.85% | -3.86% | 93.14% | 94.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1,432.65% | -103.09% | -87.25% | 100.00% |
| Cash from Investing | -6,283.72% | -232.07% | -103.92% | 51.92% | 95.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.36% | -32.44% | -12.79% | -77.06% | -91.93% |
| Issuance of Common Stock | -90.36% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.45% | -- | -- | -- | -- |
| Cash from Financing | -102.76% | 2,999.92% | -105.04% | -110.70% | 301.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.21% | 190.89% | -205.07% | -311.36% | 965.41% |